InvestLog
HALO Halozyme Therapeutics, Inc. logo

HALO Halozyme Therapeutics, Inc.

Healthcare
$68.72+0.59%ClosedMarket Cap: $8.15B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

17

Dispositions

25

Buy/Sell Ratio

0.68

Net Shares

-69,609

Shares Acquired

132,016

Shares Disposed

201,625

Total Bought ($)

$0.00

Total Sold ($)

$19.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell9,802$71.37776,480
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell9,725$64.63778,055
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell5,900$72.15770,580
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell3,575$65.46774,480
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell3,350$68.88772,330
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell2,100$68.10775,680
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell1,398$70.29786,282
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell100$67.85787,680
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell20,000$12.07787,780
Wed May 13Torley Helendirector, officer: PRESIDENT AND CEOSell10,000$12.07777,780
Thu May 07Posard Matthew L.directorSell6,040$65.876,040
Thu May 07Posard Matthew L.directorSell3,796$0.0077,835
Thu May 07Lang James PauldirectorSell6,040$65.876,040
Thu May 07Lang James PauldirectorSell3,796$0.004,685
Thu May 07Krishnan MaheshdirectorSell6,040$65.876,040